Log in to save to my catalogue

Mutation Clearance after Transplantation for Myelodysplastic Syndrome

Mutation Clearance after Transplantation for Myelodysplastic Syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6309244

Mutation Clearance after Transplantation for Myelodysplastic Syndrome

About this item

Full title

Mutation Clearance after Transplantation for Myelodysplastic Syndrome

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2018-09, Vol.379 (11), p.1028-1041

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

The risk of disease progression among patients with myelodysplastic syndrome was higher among those in whom point mutations persisted in bone marrow at day 30 after allogeneic hematopoietic stem-cell transplantation than among those without these mutations.

Alternative Titles

Full title

Mutation Clearance after Transplantation for Myelodysplastic Syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6309244

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6309244

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1804714

How to access this item